Additive effect of continuous low dose ofloxacin on erythromycin therapy for sinobronchial syndrome.
Fujimura
M
M
Third Department of Internal Medicine, Kanazawa University School of Medicine, Japan.
Ishiura
Y
Y
Saito
M
M
Shibata
K
K
Nomura
M
M
Nakatsumi
Y
Y
Matsuda
T
T
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D001991:Bronchitis / Q000188:drug therapy* / Q000382:microbiology; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D004917:Erythromycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015242:Ofloxacin / Q000627:therapeutic use; D012852:Sinusitis / Q000188:drug therapy* / Q000382:microbiology; D013183:Sputum / Q000382:microbiology; D013577:Syndrome
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D004917:Erythromycin; D015242:Ofloxacin